-
11.发明授权βd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it 有权盐酸伊伐布雷定的d结晶形式，其制备方法和含有它的药物组合物公开(公告)号：US07867995B2
公开(公告)日：2011-01-11
申请号：US12583857
申请日：2009-08-27
IPC分类号： C07D223/16 , A61K31/55 , A61P9/10
CPC分类号： C07D223/16 , B01J21/04 , B01J23/50 , B01J23/62 , B01J23/622 , B01J23/626 , B01J23/892 , B01J23/8926 , B01J35/0013 , B01J35/006 , B01J35/008 , B01J37/0211 , B01J37/0213 , C10G45/34
摘要： A βd-Crystalline form of ivabradine hydrochloride of formula (I): characterised by its powder X-ray diffraction data. Medicinal products containing the same which are useful as bradycardics.
摘要翻译： 式（I）的盐酸伊伐布拉定的D-结晶形式：其特征在于其粉末X射线衍射数据。 含有相同药物的药物可用作心动过缓药物。
-
12.发明申请Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it 审中-公开盐酸伊伐布拉定的β-晶型，其制备方法和含有它的药物组合物公开(公告)号：US20080161285A1
公开(公告)日：2008-07-03
申请号：US12072461
申请日：2008-02-26
IPC分类号： A61K31/55 , C07D223/16 , A61P9/06 , A61P9/00
CPC分类号： C07D223/16
摘要： A β-Crystalline form of ivabradine of formula (I): characterised by its powder X-ray diffraction data.Medicinal products containing the same which are useful as bradycardics.
摘要翻译： 式（I）的伊伐布拉定的β-晶型：其特征在于其粉末X射线衍射数据。 含有相同药物的药物可用作心动过缓药物。
-
13.发明申请Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it. 审中-公开盐酸伊伐布雷达的三角晶体形式，其制备方法和含有它的药物组合物。公开(公告)号：US20080161284A1
公开(公告)日：2008-07-03
申请号：US12070608
申请日：2008-02-20
IPC分类号： A61K31/55 , C07D487/00 , A61P9/04 , A61P9/10
CPC分类号： C07D223/16
摘要： A δ-crystalline form of ivabradine hydrochloride of formula (I): characterised by its powder X-ray diffraction data.Medicinal products containing the same which are useful as bradycardics.
摘要翻译： 式（I）的盐酸伊伐布拉定的δ-晶型：其特征在于其粉末X射线衍射数据。 含有相同药物的药物可用作心动过缓药物。
-
14.发明申请Gamma-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it 审中-公开盐酸伊伐布拉汀的γ结晶形式，其制备方法和含有它的药物组合物公开(公告)号：US20080153803A1
公开(公告)日：2008-06-26
申请号：US12072793
申请日：2008-02-28
IPC分类号： C07D223/16 , A61K31/55 , A61P9/06 , A61P9/00
CPC分类号： C07D223/16 , H04L51/12 , H04L51/14
摘要： A γ-Crystalline form of ivabradine hydrochloride of formula (I): characterised by its powder X-ray diffraction data.Medicinal products containing the same which are useful as bradycardics.
摘要翻译： 式（I）的盐酸伊伐布雷定的γ-晶型：其特征在于其粉末X射线衍射数据。 含有相同药物的药物可用作心动过缓药物。
-
15.发明授权γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it 有权伊伐布拉定盐酸盐的γ-晶型，其制备方法和含有它的药物组合物公开(公告)号：US07867996B2
公开(公告)日：2011-01-11
申请号：US12583885
申请日：2009-08-27
IPC分类号： C07D223/16 , A61K31/55 , A61P9/10
CPC分类号： C07D223/16 , H04L51/12 , H04L51/14
摘要： A γ-Crystalline form of ivabradine hydrochloride of formula (I): characterised by its powder X-ray diffraction data. Medicinal products containing the same which are useful as bradycardics.
摘要翻译： 式（I）的伊伐溴铵盐酸盐的γ-晶型：其特征在于其粉末X射线衍射数据。 含有相同药物的药物可用作心动过缓药物。
-
16.发明申请Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it 审中-公开盐酸伊伐布雷定的βd结晶形式，其制备方法和含有它的药物组合物公开(公告)号：US20080161286A1
公开(公告)日：2008-07-03
申请号：US12072577
申请日：2008-02-27
IPC分类号： A61K31/55 , C07D223/16 , A61P9/06
CPC分类号： C07D223/16 , B01J21/04 , B01J23/50 , B01J23/62 , B01J23/622 , B01J23/626 , B01J23/892 , B01J23/8926 , B01J35/0013 , B01J35/006 , B01J35/008 , B01J37/0211 , B01J37/0213 , C10G45/34
摘要： A βd-Crystalline form of ivabradine hydrochloride of formula (I): characterised by its powder X-ray diffraction data.Medicinal products containing the same which are useful as bradycardics.
摘要翻译： 式（I）的盐酸伊伐布拉定的betad-结晶形式：其特征在于其粉末X射线衍射数据。 含有相同药物的药物可用作心动过缓药物。
-
17.发明申请Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it 有权盐酸伊伐布雷达的三角晶体形式，其制备方法和含有它的药物组合物公开(公告)号：US20070082885A1
公开(公告)日：2007-04-12
申请号：US11544910
申请日：2006-10-09
IPC分类号： A61K31/55 , C07D223/16
CPC分类号： C07D223/16
摘要： A δ-crystalline form of ivabradine hydrochloride of formula (I) characterised by its powder X-ray diffraction data. Medicinal products containing the same which are useful as bradycardics.
摘要翻译： 式（I）的盐酸伊伐布雷定的δ结晶形式，其特征在于其粉末X射线衍射数据。 含有相同药物的药物可用作心动过缓药物。
-
公开(公告)号：US20060194965A1
公开(公告)日：2006-08-31
申请号：US11359263
申请日：2006-02-22
IPC分类号： C07D233/16
CPC分类号： C07D223/16 , B01J21/04 , B01J23/50 , B01J23/62 , B01J23/622 , B01J23/626 , B01J23/892 , B01J23/8926 , B01J35/0013 , B01J35/006 , B01J35/008 , B01J37/0211 , B01J37/0213 , C10G45/34
摘要： A βd-Crystalline form of ivabradine hydrochloride of formula (I): characterised by its powder X-ray diffraction data. Medicinal products containing the same which are useful as bradycardics.
-
19.发明申请Gamma-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it 有权盐酸伊伐布拉汀的γ结晶形式，其制备方法和含有它的药物组合物公开(公告)号：US20060194963A1
公开(公告)日：2006-08-31
申请号：US11358955
申请日：2006-02-22
IPC分类号： C07D223/16
CPC分类号： C07D223/16 , H04L51/12 , H04L51/14
摘要： A γ-Crystalline form of ivabradine hydrochloride of formula (I): characterised by its powder X-ray diffraction data. Medicinal products containing the same which are useful as bradycardics.
摘要翻译： 式（I）的盐酸伊伐布雷定的γ-晶型：其特征在于其粉末X射线衍射数据。 含有相同药物的药物可用作心动过缓药物。
-
20.发明授权Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it 有权盐酸伊伐布拉定的β-晶型，其制备方法和含有它的药物组合物公开(公告)号：US07879842B2
公开(公告)日：2011-02-01
申请号：US12589283
申请日：2009-10-21
IPC分类号： C07D223/16 , A61K31/55 , A61P9/10
CPC分类号： C07D223/16
摘要： β-Crystalline form of ivabradine of formula (I): characterised by its powder X-ray diffraction diagram. Medicinal products containing the same which are useful as bradycardics.
摘要翻译： 式（I）的伊伐布拉定的晶型：其特征在于其粉末X射线衍射图。 含有相同药物的药物可用作心动过缓药物。
-
-
-
-
-
-
-
-
-
搜索结果
24 条记录 (耗时 0.03 秒)
